: Novavax’s stock pops after WHO grants its COVID-19 vaccine emergency-use listing

Novavax Inc.’s stock NVAX soared 4.6% early Tuesday, after the company said its protein-based COVID-19 vaccine had been granted emergency-use listing by the World Health Organization. The move means that all 194 of the agency’s member states can use the Novavax vaccine for individuals aged 12 and older. The vaccine is already allowed in the U.S. under a similar emergency use authorization. “Rural or hard-to-reach areas can benefit from our vaccine’s ease of transport and storage profile,”...